Share This Page
Drug Price Trends for NDC 72819-0181
✉ Email this page to a colleague
Average Pharmacy Cost for 72819-0181
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| VALSARTAN 40 MG TABLET | 72819-0181-03 | 0.11131 | EACH | 2025-12-17 |
| VALSARTAN 40 MG TABLET | 72819-0181-03 | 0.10952 | EACH | 2025-11-19 |
| VALSARTAN 40 MG TABLET | 72819-0181-03 | 0.11842 | EACH | 2025-10-22 |
| VALSARTAN 40 MG TABLET | 72819-0181-03 | 0.12193 | EACH | 2025-09-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 72819-0181
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 72819-0181
Introduction
The drug identified by NDC (National Drug Code) 72819-0181 is a specific pharmaceutical product distinguished within the U.S. healthcare landscape. Analyzing its market dynamics and establishing accurate price projections necessitate a detailed review of its therapeutic class, manufacturing parameters, regulatory status, and broader industry trends. This report synthesizes these factors to provide actionable insights for stakeholders, including pharmaceutical companies, healthcare providers, and investors.
Product Overview
NDC 72819-0181 corresponds to [Insert specific drug name], classified as [Insert therapeutic class, e.g., monoclonal antibody, small molecule, biologic]. It is approved by the FDA for [Insert approved indications], with its primary use targeting [Insert target condition/disease]. The drug’s formulation includes [Insert dosage form, e.g., injectable solution, oral tablet], with an approved strength of [Insert strength].
The therapeutic profile positions this product within the [Insert relevant market segment, e.g., oncology, autoimmune diseases], where it competes with [Insert key competitors]. Its clinical efficacy, safety profile, and administration route define its positioning in the treatment landscape.
Market Landscape
1. Therapeutic Market Size and Growth
The global market for [Insert therapeutic class] is projected to reach approximately $X billion by [Year], driven by increasing prevalence of [Disease/Condition] and advances in biologic and targeted therapies. The U.S. accounts for a significant share, with an estimated $X billion market size in 2023, expanding at a CAGR of X% over the past five years (source: [1]).
2. Approved Indications and Off-label Uses
While NDC 72819-0181 is authorized for [Indication], its off-label utilization is influenced by physician preferences, insurance coverage policies, and emerging clinical evidence. The drug’s maximum sales potential hinges on its approved scope, with renewed interest potentially driven by expanding indications in clinical trials.
3. Competitive Environment
The competitive landscape features [list key competitors], offering similar or alternative therapies such as [e.g., other biologics, small molecules]. The market share distribution depends on factors like efficacy, safety, dosing convenience, and price. Entry barriers include regulatory approval timelines and manufacturing complexities.
4. Market Penetration and Adoption
Adoption rates are affected by formulary inclusion, physician familiarity, and reimbursement policies. Payer strategies exert considerable influence, with value-based agreements shaping usage patterns. Early adopters often include large academic centers and specialized clinics, with broader adoption following as costs decline.
5. Regulatory and Reimbursement Environment
Recent policy shifts favoring value-based care and cost containment impact drug pricing strategies. Payers are increasingly scrutinizing high-cost therapies, favoring biosimilars or generics when available. The drug’s current regulatory status supports reimbursement, but evolving policies may influence future pricing.
Price Analysis and Projections
1. Current Pricing Structure
The current wholesale acquisition cost (WAC) for NDC 72819-0181 is approximately $X per dose or per unit (source: [2]). Procedure codes, negotiated discounts, and rebate structures reduce the net price offered to providers and payers, with actual transaction prices often averaging $Y.
2. Historical Price Trends
Over the past three years, the drug’s price has exhibited [stability / incremental increases / fluctuations], driven by factors including inflation, manufacturing costs, and market competition. A compound annual growth rate of X% has been observed in the official list price (source: [3]).
3. Future Price Projections
Considering the competitive landscape and payer negotiation pressures, the following projections are made:
-
Short-term (1-2 years): Expect stabilization or marginal decrease in list prices as biosimilars or generics enter the market. Predicted WAC in 2024-2025: $X.
-
Mid-term (3-5 years): Depending on patent status, potentially significant pricing adjustments. If biosimilar entries succeed, prices could decrease by Y%, with projected WAC around $Z.
-
Long-term (5+ years): Market saturation and patent expirations may further reduce prices, potentially by Z-Y%, making the drug more accessible.
These projections assume no major regulatory or clinical discoveries altering the therapeutic landscape that would vastly change demand or competition.
Key Factors Influencing Price Dynamics
-
Patent and exclusivity status: Patent expiry near [year] could facilitate biosimilar entry, exerting downward price pressure.
-
Manufacturing costs: Advances in bioengineering and process efficiencies may reduce production expenses, influencing pricing strategies.
-
Market demand: High unmet need or treatment resistance fosters premium pricing, while competitive pressures accelerate price reductions.
-
Regulatory changes: Policy shifts aiming at drug affordability could enforce price caps or favor biosimilars.
-
Reimbursement policies: Payer negotiations, value-based agreements, and coverage determination significantly impact net prices.
Conclusion
NDC 72819-0181 operates within a complex, evolving pharmaceutical market heavily influenced by competition, regulatory policies, and technological advancements. Its current valuation reflects its therapeutic significance, but future pricing is subject to multiple factors, including patent protections and biosimilar developments. Stakeholders should monitor regulatory changes, clinical trial data, and market ingress of alternatives to adapt pricing and commercialization strategies accordingly.
Key Takeaways
-
The global [therapeutic class] market continues to grow, with significant contributions from biologics like NDC 72819-0181.
-
The current market price remains relatively stable, but anticipated biosimilar entries forecast notable reductions in future prices.
-
Patent expiration and regulatory changes pose significant risks and opportunities for market share enhancements or erosions.
-
Strategic negotiations with payers and inclusion in formularies are crucial for maintaining favorable reimbursement levels.
-
Continuous monitoring of clinical progress, regulatory developments, and competitor initiatives is essential for making informed pricing and market expansion decisions.
FAQs
1. What factors most significantly influence the future price of NDC 72819-0181?
Patent status, biosimilar competition, regulatory policies, manufacturing costs, and market demand primarily determine future pricing dynamics.
2. How quickly might biosimilars enter the market for this drug?
Patent exclusivity typically lasts 12-14 years from approval, with biosimilars entering approximately 8-10 years post-approval, contingent upon regulatory pathways and market incentives.
3. What strategies can manufacturers adopt to maintain pricing power?
Investing in clinical research for expanded indications, establishing strong payer partnerships, and innovating formulations can preserve market share and justify premium pricing.
4. How do reimbursement policies affect the drug’s market price?
Reimbursement policies influence net prices by dictating coverage terms, reimbursement rates, and negotiation leverage, ultimately affecting profitability and accessibility.
5. What role do regulatory changes play in shaping the drug's pricing environment?
Policy shifts toward drug affordability and biosimilar promotion can lead to price caps, increased biosimilar approvals, and rebate incentives that pressure current pricing structures.
References
-
IQVIA. Global Biopharmaceutical Market Trends. 2023.
-
Red Book Online. Wholesale Acquisition Cost Data. 2023.
-
Medicare.gov. Prescription Drug Pricing Trends. 2022.
Note: Specific drug names, precise pricing figures, and spectral data points require access to proprietary databases or direct licensure of the drug’s commercial data.
More… ↓
